On the above bi-weekly chart price action has corrected over 95% since the sell signal (not shown). Now is an excellent long moment. Why?
1) A strong buy signal (not shown).
2) Price action is printing strong bullish divergence, look left.
3) No stock splits.
Is it possible price action falls further? Sure.
Is it probable? No.
Ww
Type: investment
Risk: <=6%...
DBV Technologies Spikes on Positive FDA Communication
DBV Technologies received positive responses from the U.S. Food and Drug Administration regarding its application for a peanut allergy treatment.
The U.S. FDA provided type A meeting requests to the questions the French company submitted in October following its receipt of a complete response letter in...
DBV Technologies Reports H1-20
themarketsignal.com
DBV TECHNOLOGIES ADR (NASDAQ:DBVT) is reflecting bullish signals with a RSI of 19.89. The clinical-stage biopharmaceutical company reported financial figures for the H1-20. DBVT reported €225.9 million cash and cash equivalents at the end of H1-20. This compares with €172.0 million in the previous half year ending...
DBV Technologies Reports H1-20
themarketsignal.com
DBV TECHNOLOGIES ADR (NASDAQ:DBVT) is reflecting bullish signals with a RSI of 19.89. The clinical-stage biopharmaceutical company reported financial figures for the H1-20. DBVT reported €225.9 million cash and cash equivalents at the end of H1-20. This compares with €172.0 million in the previous half year ending...
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults.
DBVT is forming a nice fallen angel formation. It had a nice rally & now pulled back to moving average. We think it will continue upward from here.
* Trade Criteria *
Date First Found- November 21, 2017
Pattern/Why- Fallen angel
Entry Target Criteria- Present price ($24.43)
Exit Target Criteria- 1st Target $27.83, 2nd Target $31.62
Stop Loss Criteria- $22.58...
